Latest Partnerships News

EZZ Life Science Holdings delivered a robust Q2 FY25 with a 16.6% increase in customer receipts and a 308% jump in operating cash flows, while gearing up for US market entry and expanding its global footprint.

Tinybeans Group Limited reported a 9% increase in quarterly subscription revenue to US$0.80 million in Q2 FY25, alongside a significant reduction in cash burn and operational expenses following a major restructure.

Forbidden Foods Limited has more than doubled its group revenues in Q2 FY25 following the acquisition of Oat Milk Goodness, driven by expanded retail distribution and strong ecommerce growth.

Insignia Financial reported a robust 2.2% increase in Funds Under Management and Administration to $326.8 billion in 2Q25, underpinned by strong net inflows and strategic milestones including the IT separation from NAB and the unveiling of its Vision2030 growth strategy.

Firebrick Pharma has made notable progress expanding its Nasodine nasal spray in Singapore, securing major distribution and marketing agreements that set the stage for retail sales growth in 2025.

Pure Hydrogen’s subsidiary HDrive International has secured a significant AUD$2 million order from logistics giant TOLL Transport for two Taurus 70t hydrogen fuel cell prime movers, marking a pivotal step in the company’s commercial vehicle sales expansion.

RocketDNA has reported its strongest quarter yet, breaking the $2 million revenue barrier and marking its first international export of the xBot® autonomous drone platform to a major African mining operation.

Great Divide Mining has completed its due diligence on the Adelong Gold Project, paving the way for a strategic stake acquisition and operational control aimed at resuming gold production within a year.

S2 Resources reports promising exploration advances across multiple projects, including new targets at Warraweena and West Murchison, ongoing drilling at Glenlogan, and the launch of three new Victorian gold projects. The company maintains a solid cash position to support its $1.5 million planned expenditure next quarter.

Cyclopharm has inked a pivotal three-year agreement with HCA Healthcare, enabling deployment of its Technegas® lung imaging technology across up to 169 US nuclear medicine departments. This deal marks a major step in expanding Technegas®’ footprint in the American healthcare market.

Iceni Gold Limited reports significant expansion of the Guyer gold anomaly at its 14 Mile Well Project, unveiling robust gold mineralisation across a broad footprint. The company prepares for a major reverse circulation drilling campaign backed by Gold Road Resources.

Icetana Limited reports a challenging December quarter with declining revenues but secures significant new contracts and launches a fully underwritten $2.65 million rights issue.